- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03272360
Endometriosis Biomarker Discovery Study (EMBARK)
August 31, 2017 updated by: Myriad Genetic Laboratories, Inc.
A Prospective Sample Collection Study in Patients With Pelvic Pain Undergoing Laparoscopy for Biomarker Identification in Endometriosis
This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain.
Patients undergoing laparoscopy for evaluation of chronic pelvic pain or elective tubal ligation will be enrolled for collection of tissue samples at the time of laparoscopy.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
This study will be a prospective collection of blood, urine, and endometrial tissue from women with chronic pelvic pain symptoms, with or without infertility, who require evaluation by laparoscopy.
Women undergoing laparoscopy for elective tubal ligation will also be investigated similarly and serve as the negative control.
Subjects will be queried regarding sociodemographic characteristics, medical and reproductive history, pain and lifestyle as well as assessment for differential diagnoses such as interstitial cystitis and idiopathic bowel syndrome.
Endometriosis severity will be captured by rASRM staging during laparoscopy.
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women seeking care at OB/GYN clinics and fertility centers
Description
Inclusion Criteria:
- Able to give informed consent.
- Aged 18-45 years old who has a regular menstrual cycle (26 to 32 days in length).
- Undergoing a planned diagnostic or therapeutic laparoscopy for the indication of pelvic pain or for elective tubal ligation.
- One prior pregnancy for tubal ligation patients.
Exclusion Criteria:
- Prior surgical diagnosis of endometriosis.
- Currently pregnant or breastfeeding.
- Clinical suspicion of pelvic inflammatory disease (PID) or urinary tract infection.
- Current malignancy except non-melanoma skin cancer adequately treated.
- Known major systemic disease, including but not limited to inflammatory disease, autoimmune disease.
- Use of immunosuppressants in the past 3 months.
- Use of injectable reproductive hormonal therapy within the past 3 months and have not menstruated since last dose.
- If reproductive hormonal implant has been used in the past, it must have been removed > 3 months prior to study entry and subject must have menstruated since removal.
- Use of intrauterine device (IUD) in the past 3 months.
- Use of any other reproductive hormone therapy within the past 3 months, except for oral contraceptives (OCPs).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Chronic Pelvic Pain
|
Elective Tubal Ligation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The identification of biomarker(s) that are differentially expressed in endometriosis in the context of pelvic pain
Time Frame: Baseline (pre-operative)
|
The primary variables will be the DiscoveryMAP analytes identified in blood and/or urine and the mRNA transcriptome in endometrial tissue.
DiscoveryMAP is a comprehensive, quantitative platform of immunoassays evaluating multiple analytes in various body system categories: cytokines, chemokines, metabolic markers, hormones, growth factors, tissue remodeling proteins, angiogenesis markers, acute phase reactants, and cancer markers
|
Baseline (pre-operative)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The identification of biomarker(s) that are associated with endometriosis severity
Time Frame: Baseline (pre-operative)
|
The secondary variables will be measures of endometriosis severity: rASRM staging of endometriosis and pain severity from clinical survey
|
Baseline (pre-operative)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (ANTICIPATED)
June 1, 2017
Study Completion (ANTICIPATED)
June 1, 2017
Study Registration Dates
First Submitted
September 6, 2016
First Submitted That Met QC Criteria
August 31, 2017
First Posted (ACTUAL)
September 5, 2017
Study Record Updates
Last Update Posted (ACTUAL)
September 5, 2017
Last Update Submitted That Met QC Criteria
August 31, 2017
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EP-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly